 | • レポートコード：MRC2-11QY05794 • 出版社/出版日：QYResearch / 2020年11月20日 ※2024年版があります。お問い合わせください。 • レポート形態：英文、PDF、116ページ • 納品方法：Eメール（納期：2~3日） • 産業分類：医療、製薬 |
| Single User | ￥585,000 (USD3,900) | ▷ お問い合わせ |
| Multi User | ￥877,500 (USD5,850) | ▷ お問い合わせ |
| Enterprise License | ￥1,170,000 (USD7,800) | ▷ お問い合わせ |
• お支払方法：銀行振込（納品後、ご請求書送付）
レポート概要
| 当調査資料はエソメプラゾールのグローバル市場について調査・分析したレポートです。種類別（カプセル、タブレット、その他）市場規模、用途別（胃食道逆流症、十二指腸潰瘍、その他）市場規模、地域別（北米、米国、カナダ、ヨーロッパ、ドイツ、フランス、イギリス、イタリア、ロシア、アジア、日本、中国、韓国、インド、オーストラリア、台湾、中南米、メキシコ、ブラジル、アルゼンチン、中東・アフリカ、トルコ、サウジアラビア、UAE等）市場規模データ、主な企業情報と企業別市場シェア等が収録されています。 ・調査範囲 ・エグゼクティブサマリー ・企業別エソメプラゾールの競争状況、市場シェア ・世界のエソメプラゾール市場：種類別市場規模 2015年-2020年（カプセル、タブレット、その他） ・世界のエソメプラゾール市場：種類別市場規模予測 2021年-2026年（カプセル、タブレット、その他） ・世界のエソメプラゾール市場：用途別市場規模 2015年-2020年（胃食道逆流症、十二指腸潰瘍、その他） ・世界のエソメプラゾール市場：用途別市場規模予測 2021年-2026年（胃食道逆流症、十二指腸潰瘍、その他） ・北米のエソメプラゾール市場分析：米国、カナダ ・ヨーロッパのエソメプラゾール市場分析：ドイツ、フランス、イギリス、イタリア、ロシア等 ・アジアのエソメプラゾール市場分析：日本、中国、韓国、インド、オーストラリア、台湾等 ・中南米のエソメプラゾール市場分析：メキシコ、ブラジル、アルゼンチン等 ・中東・アフリカのエソメプラゾール市場分析：トルコ、サウジアラビア、UAE等 ・企業情報（企業概要、製品概要、販売量、企業動向） - 掲載企業（変更可能性あり）：AstraZeneca AB、Sandoz、Actavis、Teva.、Mylan、KernPharm、Garmish Pharmaceuticals、Sanofi、Mepha、Saval Pharmaceutical、Stada、Blaskov、CQ Lummy ・地域別市場規模予測（2021年-2026年）：北米市場、ヨーロッパ市場、アジア市場、中南米市場、中東・アフリカ市場 ・市場機会、課題、リスク、環境分析 ・バリューチェーン、販売チャネル分析 ・調査の結論 |
Esomeprazole drug market in this report.
Market Analysis and Insights: Global Esomeprazole Market
The global Esomeprazole market size is projected to reach US$ XX million by 2026, from US$ XX million in 2020, at a CAGR of XX%% during 2021-2026.
Global Esomeprazole Scope and Market Size
Esomeprazole market is segmented by Type, and by Application. Players, stakeholders, and other participants in the global Esomeprazole market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on sales, revenue and forecast by Type and by Application for the period 2015-2026.
Segment by Type, the Esomeprazole market is segmented into
Capsule
Tablet
Others
Segment by Application, the Esomeprazole market is segmented into
Gastroesophageal Reflux Disease
Duodenal Ulcers
Others
Regional and Country-level Analysis
The Esomeprazole market is analysed and market size information is provided by regions (countries).
The key regions covered in the Esomeprazole market report are North America, Europe, Asia Pacific, Latin America, Middle East and Africa. It also covers key regions (countries), viz, U.S., Canada, Germany, France, U.K., Italy, Russia, China, Japan, South Korea, India, Australia, Taiwan, Indonesia, Thailand, Malaysia, Philippines, Vietnam, Mexico, Brazil, Turkey, Saudi Arabia, U.A.E, etc.
The report includes country-wise and region-wise market size for the period 2015-2026. It also includes market size and forecast by Type, and by Application segment in terms of sales and revenue for the period 2015-2026.
Competitive Landscape and Esomeprazole Market Share Analysis
Esomeprazole market competitive landscape provides details and data information by players. The report offers comprehensive analysis and accurate statistics on revenue by the player for the period 2015-2020. It also offers detailed analysis supported by reliable statistics on revenue (global and regional level) by players for the period 2015-2020. Details included are company description, major business, company total revenue and the sales, revenue generated in Esomeprazole business, the date to enter into the Esomeprazole market, Esomeprazole product introduction, recent developments, etc.
The major vendors covered:
AstraZeneca AB
Sandoz
Actavis
Teva.
Mylan
KernPharm
Garmish Pharmaceuticals
Sanofi
Mepha
Saval Pharmaceutical
Stada
Blaskov
CQ Lummy
1 Study Coverage
1.1 Esomeprazole Product Introduction
1.2 Market Segments
1.3 Key Esomeprazole Manufacturers Covered: Ranking by Revenue
1.4 Market by Type
1.4.1 Global Esomeprazole Market Size Growth Rate by Type
1.4.2 Capsule
1.4.3 Tablet
1.4.4 Others
1.5 Market by Application
1.5.1 Global Esomeprazole Market Size Growth Rate by Application
1.5.2 Gastroesophageal Reflux Disease
1.5.3 Duodenal Ulcers
1.5.4 Others
1.6 Study Objectives
1.7 Years Considered
2 Executive Summary
2.1 Global Esomeprazole Market Size, Estimates and Forecasts
2.1.1 Global Esomeprazole Revenue 2015-2026
2.1.2 Global Esomeprazole Sales 2015-2026
2.2 Global Esomeprazole, Market Size by Producing Regions: 2015 VS 2020 VS 2026
2.2.1 Global Esomeprazole Retrospective Market Scenario in Sales by Region: 2015-2020
2.2.2 Global Esomeprazole Retrospective Market Scenario in Revenue by Region: 2015-2020
3 Global Esomeprazole Competitor Landscape by Players
3.1 Esomeprazole Sales by Manufacturers
3.1.1 Esomeprazole Sales by Manufacturers (2015-2020)
3.1.2 Esomeprazole Sales Market Share by Manufacturers (2015-2020)
3.2 Esomeprazole Revenue by Manufacturers
3.2.1 Esomeprazole Revenue by Manufacturers (2015-2020)
3.2.2 Esomeprazole Revenue Share by Manufacturers (2015-2020)
3.2.3 Global Esomeprazole Market Concentration Ratio (CR5 and HHI) (2015-2020)
3.2.4 Global Top 10 and Top 5 Companies by Esomeprazole Revenue in 2019
3.2.5 Global Esomeprazole Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
3.3 Esomeprazole Price by Manufacturers
3.4 Esomeprazole Manufacturing Base Distribution, Product Types
3.4.1 Esomeprazole Manufacturers Manufacturing Base Distribution, Headquarters
3.4.2 Manufacturers Esomeprazole Product Type
3.4.3 Date of International Manufacturers Enter into Esomeprazole Market
3.5 Manufacturers Mergers & Acquisitions, Expansion Plans
4 Market Size by Type (2015-2026)
4.1 Global Esomeprazole Market Size by Type (2015-2020)
4.1.1 Global Esomeprazole Sales by Type (2015-2020)
4.1.2 Global Esomeprazole Revenue by Type (2015-2020)
4.1.3 Esomeprazole Average Selling Price (ASP) by Type (2015-2026)
4.2 Global Esomeprazole Market Size Forecast by Type (2021-2026)
4.2.1 Global Esomeprazole Sales Forecast by Type (2021-2026)
4.2.2 Global Esomeprazole Revenue Forecast by Type (2021-2026)
4.2.3 Esomeprazole Average Selling Price (ASP) Forecast by Type (2021-2026)
4.3 Global Esomeprazole Market Share by Price Tier (2015-2020): Low-End, Mid-Range and High-End
5 Market Size by Application (2015-2026)
5.1 Global Esomeprazole Market Size by Application (2015-2020)
5.1.1 Global Esomeprazole Sales by Application (2015-2020)
5.1.2 Global Esomeprazole Revenue by Application (2015-2020)
5.1.3 Esomeprazole Price by Application (2015-2020)
5.2 Esomeprazole Market Size Forecast by Application (2021-2026)
5.2.1 Global Esomeprazole Sales Forecast by Application (2021-2026)
5.2.2 Global Esomeprazole Revenue Forecast by Application (2021-2026)
5.2.3 Global Esomeprazole Price Forecast by Application (2021-2026)
6 North America
6.1 North America Esomeprazole by Country
6.1.1 North America Esomeprazole Sales by Country
6.1.2 North America Esomeprazole Revenue by Country
6.1.3 U.S.
6.1.4 Canada
6.2 North America Esomeprazole Market Facts & Figures by Type
6.3 North America Esomeprazole Market Facts & Figures by Application
7 Europe
7.1 Europe Esomeprazole by Country
7.1.1 Europe Esomeprazole Sales by Country
7.1.2 Europe Esomeprazole Revenue by Country
7.1.3 Germany
7.1.4 France
7.1.5 U.K.
7.1.6 Italy
7.1.7 Russia
7.2 Europe Esomeprazole Market Facts & Figures by Type
7.3 Europe Esomeprazole Market Facts & Figures by Application
8 Asia Pacific
8.1 Asia Pacific Esomeprazole by Region
8.1.1 Asia Pacific Esomeprazole Sales by Region
8.1.2 Asia Pacific Esomeprazole Revenue by Region
8.1.3 China
8.1.4 Japan
8.1.5 South Korea
8.1.6 India
8.1.7 Australia
8.1.8 Taiwan
8.1.9 Indonesia
8.1.10 Thailand
8.1.11 Malaysia
8.1.12 Philippines
8.1.13 Vietnam
8.2 Asia Pacific Esomeprazole Market Facts & Figures by Type
8.3 Asia Pacific Esomeprazole Market Facts & Figures by Application
9 Latin America
9.1 Latin America Esomeprazole by Country
9.1.1 Latin America Esomeprazole Sales by Country
9.1.2 Latin America Esomeprazole Revenue by Country
9.1.3 Mexico
9.1.4 Brazil
9.1.5 Argentina
9.2 Central & South America Esomeprazole Market Facts & Figures by Type
9.3 Central & South America Esomeprazole Market Facts & Figures by Application
10 Middle East and Africa
10.1 Middle East and Africa Esomeprazole by Country
10.1.1 Middle East and Africa Esomeprazole Sales by Country
10.1.2 Middle East and Africa Esomeprazole Revenue by Country
10.1.3 Turkey
10.1.4 Saudi Arabia
10.1.5 U.A.E
10.2 Middle East and Africa Esomeprazole Market Facts & Figures by Type
10.3 Middle East and Africa Esomeprazole Market Facts & Figures by Application
11 Company Profiles
11.1 AstraZeneca AB
11.1.1 AstraZeneca AB Corporation Information
11.1.2 AstraZeneca AB Description and Business Overview
11.1.3 AstraZeneca AB Sales, Revenue and Gross Margin (2015-2020)
11.1.4 AstraZeneca AB Esomeprazole Products Offered
11.1.5 AstraZeneca AB Related Developments
11.2 Sandoz
11.2.1 Sandoz Corporation Information
11.2.2 Sandoz Description and Business Overview
11.2.3 Sandoz Sales, Revenue and Gross Margin (2015-2020)
11.2.4 Sandoz Esomeprazole Products Offered
11.2.5 Sandoz Related Developments
11.3 Actavis
11.3.1 Actavis Corporation Information
11.3.2 Actavis Description and Business Overview
11.3.3 Actavis Sales, Revenue and Gross Margin (2015-2020)
11.3.4 Actavis Esomeprazole Products Offered
11.3.5 Actavis Related Developments
11.4 Teva.
11.4.1 Teva. Corporation Information
11.4.2 Teva. Description and Business Overview
11.4.3 Teva. Sales, Revenue and Gross Margin (2015-2020)
11.4.4 Teva. Esomeprazole Products Offered
11.4.5 Teva. Related Developments
11.5 Mylan
11.5.1 Mylan Corporation Information
11.5.2 Mylan Description and Business Overview
11.5.3 Mylan Sales, Revenue and Gross Margin (2015-2020)
11.5.4 Mylan Esomeprazole Products Offered
11.5.5 Mylan Related Developments
11.6 KernPharm
11.6.1 KernPharm Corporation Information
11.6.2 KernPharm Description and Business Overview
11.6.3 KernPharm Sales, Revenue and Gross Margin (2015-2020)
11.6.4 KernPharm Esomeprazole Products Offered
11.6.5 KernPharm Related Developments
11.7 Garmish Pharmaceuticals
11.7.1 Garmish Pharmaceuticals Corporation Information
11.7.2 Garmish Pharmaceuticals Description and Business Overview
11.7.3 Garmish Pharmaceuticals Sales, Revenue and Gross Margin (2015-2020)
11.7.4 Garmish Pharmaceuticals Esomeprazole Products Offered
11.7.5 Garmish Pharmaceuticals Related Developments
11.8 Sanofi
11.8.1 Sanofi Corporation Information
11.8.2 Sanofi Description and Business Overview
11.8.3 Sanofi Sales, Revenue and Gross Margin (2015-2020)
11.8.4 Sanofi Esomeprazole Products Offered
11.8.5 Sanofi Related Developments
11.9 Mepha
11.9.1 Mepha Corporation Information
11.9.2 Mepha Description and Business Overview
11.9.3 Mepha Sales, Revenue and Gross Margin (2015-2020)
11.9.4 Mepha Esomeprazole Products Offered
11.9.5 Mepha Related Developments
11.10 Saval Pharmaceutical
11.10.1 Saval Pharmaceutical Corporation Information
11.10.2 Saval Pharmaceutical Description and Business Overview
11.10.3 Saval Pharmaceutical Sales, Revenue and Gross Margin (2015-2020)
11.10.4 Saval Pharmaceutical Esomeprazole Products Offered
11.10.5 Saval Pharmaceutical Related Developments
11.1 AstraZeneca AB
11.1.1 AstraZeneca AB Corporation Information
11.1.2 AstraZeneca AB Description and Business Overview
11.1.3 AstraZeneca AB Sales, Revenue and Gross Margin (2015-2020)
11.1.4 AstraZeneca AB Esomeprazole Products Offered
11.1.5 AstraZeneca AB Related Developments
11.12 Blaskov
11.12.1 Blaskov Corporation Information
11.12.2 Blaskov Description and Business Overview
11.12.3 Blaskov Sales, Revenue and Gross Margin (2015-2020)
11.12.4 Blaskov Products Offered
11.12.5 Blaskov Related Developments
11.13 CQ Lummy
11.13.1 CQ Lummy Corporation Information
11.13.2 CQ Lummy Description and Business Overview
11.13.3 CQ Lummy Sales, Revenue and Gross Margin (2015-2020)
11.13.4 CQ Lummy Products Offered
11.13.5 CQ Lummy Related Developments
12 Future Forecast by Regions (Countries) (2021-2026)
12.1 Esomeprazole Market Estimates and Projections by Region
12.1.1 Global Esomeprazole Sales Forecast by Regions 2021-2026
12.1.2 Global Esomeprazole Revenue Forecast by Regions 2021-2026
12.2 North America Esomeprazole Market Size Forecast (2021-2026)
12.2.1 North America: Esomeprazole Sales Forecast (2021-2026)
12.2.2 North America: Esomeprazole Revenue Forecast (2021-2026)
12.2.3 North America: Esomeprazole Market Size Forecast by Country (2021-2026)
12.3 Europe Esomeprazole Market Size Forecast (2021-2026)
12.3.1 Europe: Esomeprazole Sales Forecast (2021-2026)
12.3.2 Europe: Esomeprazole Revenue Forecast (2021-2026)
12.3.3 Europe: Esomeprazole Market Size Forecast by Country (2021-2026)
12.4 Asia Pacific Esomeprazole Market Size Forecast (2021-2026)
12.4.1 Asia Pacific: Esomeprazole Sales Forecast (2021-2026)
12.4.2 Asia Pacific: Esomeprazole Revenue Forecast (2021-2026)
12.4.3 Asia Pacific: Esomeprazole Market Size Forecast by Region (2021-2026)
12.5 Latin America Esomeprazole Market Size Forecast (2021-2026)
12.5.1 Latin America: Esomeprazole Sales Forecast (2021-2026)
12.5.2 Latin America: Esomeprazole Revenue Forecast (2021-2026)
12.5.3 Latin America: Esomeprazole Market Size Forecast by Country (2021-2026)
12.6 Middle East and Africa Esomeprazole Market Size Forecast (2021-2026)
12.6.1 Middle East and Africa: Esomeprazole Sales Forecast (2021-2026)
12.6.2 Middle East and Africa: Esomeprazole Revenue Forecast (2021-2026)
12.6.3 Middle East and Africa: Esomeprazole Market Size Forecast by Country (2021-2026)
13 Market Opportunities, Challenges, Risks and Influences Factors Analysis
13.1 Market Opportunities and Drivers
13.2 Market Challenges
13.3 Market Risks/Restraints
13.4 Porter’s Five Forces Analysis
13.5 Primary Interviews with Key Esomeprazole Players (Opinion Leaders)
14 Value Chain and Sales Channels Analysis
14.1 Value Chain Analysis
14.2 Esomeprazole Customers
14.3 Sales Channels Analysis
14.3.1 Sales Channels
14.3.2 Distributors
15 Research Findings and Conclusion
16 Appendix
16.1 Research Methodology
16.1.1 Methodology/Research Approach
16.1.2 Data Source
16.2 Author Details
16.3 Disclaimer
Table 1. Esomeprazole Market Segments
Table 2. Ranking of Global Top Esomeprazole Manufacturers by Revenue (US$ Million) in 2019
Table 3. Global Esomeprazole Market Size Growth Rate by Type 2020-2026 (K Units) & (US$ Million)
Table 4. Major Manufacturers of Capsule
Table 5. Major Manufacturers of Tablet
Table 6. Major Manufacturers of Others
Table 7. Global Esomeprazole Market Size Growth Rate by Application 2020-2026 (K Units)
Table 8. Global Esomeprazole Market Size by Region (K Units) & (US$ Million): 2020 VS 2026
Table 9. Global Esomeprazole Sales by Regions 2015-2020 (K Units)
Table 10. Global Esomeprazole Sales Market Share by Regions (2015-2020)
Table 11. Global Esomeprazole Revenue by Regions 2015-2020 (US$ Million)
Table 12. Global Esomeprazole Sales by Manufacturers (2015-2020) (K Units)
Table 13. Global Esomeprazole Sales Share by Manufacturers (2015-2020)
Table 14. Global Esomeprazole Manufacturers Market Concentration Ratio (CR5 and HHI) (2015-2020)
Table 15. Global Esomeprazole by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Esomeprazole as of 2019)
Table 16. Esomeprazole Revenue by Manufacturers (2015-2020) (US$ Million)
Table 17. Esomeprazole Revenue Share by Manufacturers (2015-2020)
Table 18. Key Manufacturers Esomeprazole Price (2015-2020) (USD/Unit)
Table 19. Esomeprazole Manufacturers Manufacturing Base Distribution and Headquarters
Table 20. Manufacturers Esomeprazole Product Type
Table 21. Date of International Manufacturers Enter into Esomeprazole Market
Table 22. Manufacturers Mergers & Acquisitions, Expansion Plans
Table 23. Global Esomeprazole Sales by Type (2015-2020) (K Units)
Table 24. Global Esomeprazole Sales Share by Type (2015-2020)
Table 25. Global Esomeprazole Revenue by Type (2015-2020) (US$ Million)
Table 26. Global Esomeprazole Revenue Share by Type (2015-2020)
Table 27. Esomeprazole Average Selling Price (ASP) by Type 2015-2020 (USD/Unit)
Table 28. Global Esomeprazole Sales by Application (2015-2020) (K Units)
Table 29. Global Esomeprazole Sales Share by Application (2015-2020)
Table 30. North America Esomeprazole Sales by Country (2015-2020) (K Units)
Table 31. North America Esomeprazole Sales Market Share by Country (2015-2020)
Table 32. North America Esomeprazole Revenue by Country (2015-2020) (US$ Million)
Table 33. North America Esomeprazole Revenue Market Share by Country (2015-2020)
Table 34. North America Esomeprazole Sales by Type (2015-2020) (K Units)
Table 35. North America Esomeprazole Sales Market Share by Type (2015-2020)
Table 36. North America Esomeprazole Sales by Application (2015-2020) (K Units)
Table 37. North America Esomeprazole Sales Market Share by Application (2015-2020)
Table 38. Europe Esomeprazole Sales by Country (2015-2020) (K Units)
Table 39. Europe Esomeprazole Sales Market Share by Country (2015-2020)
Table 40. Europe Esomeprazole Revenue by Country (2015-2020) (US$ Million)
Table 41. Europe Esomeprazole Revenue Market Share by Country (2015-2020)
Table 42. Europe Esomeprazole Sales by Type (2015-2020) (K Units)
Table 43. Europe Esomeprazole Sales Market Share by Type (2015-2020)
Table 44. Europe Esomeprazole Sales by Application (2015-2020) (K Units)
Table 45. Europe Esomeprazole Sales Market Share by Application (2015-2020)
Table 46. Asia Pacific Esomeprazole Sales by Region (2015-2020) (K Units)
Table 47. Asia Pacific Esomeprazole Sales Market Share by Region (2015-2020)
Table 48. Asia Pacific Esomeprazole Revenue by Region (2015-2020) (US$ Million)
Table 49. Asia Pacific Esomeprazole Revenue Market Share by Region (2015-2020)
Table 50. Asia Pacific Esomeprazole Sales by Type (2015-2020) (K Units)
Table 51. Asia Pacific Esomeprazole Sales Market Share by Type (2015-2020)
Table 52. Asia Pacific Esomeprazole Sales by Application (2015-2020) (K Units)
Table 53. Asia Pacific Esomeprazole Sales Market Share by Application (2015-2020)
Table 54. Latin America Esomeprazole Sales by Country (2015-2020) (K Units)
Table 55. Latin America Esomeprazole Sales Market Share by Country (2015-2020)
Table 56. Latin Americaa Esomeprazole Revenue by Country (2015-2020) (US$ Million)
Table 57. Latin America Esomeprazole Revenue Market Share by Country (2015-2020)
Table 58. Latin America Esomeprazole Sales by Type (2015-2020) (K Units)
Table 59. Latin America Esomeprazole Sales Market Share by Type (2015-2020)
Table 60. Latin America Esomeprazole Sales by Application (2015-2020) (K Units)
Table 61. Latin America Esomeprazole Sales Market Share by Application (2015-2020)
Table 62. Middle East and Africa Esomeprazole Sales by Country (2015-2020) (K Units)
Table 63. Middle East and Africa Esomeprazole Sales Market Share by Country (2015-2020)
Table 64. Middle East and Africa Esomeprazole Revenue by Country (2015-2020) (US$ Million)
Table 65. Middle East and Africa Esomeprazole Revenue Market Share by Country (2015-2020)
Table 66. Middle East and Africa Esomeprazole Sales by Type (2015-2020) (K Units)
Table 67. Middle East and Africa Esomeprazole Sales Market Share by Type (2015-2020)
Table 68. Middle East and Africa Esomeprazole Sales by Application (2015-2020) (K Units)
Table 69. Middle East and Africa Esomeprazole Sales Market Share by Application (2015-2020)
Table 70. AstraZeneca AB Corporation Information
Table 71. AstraZeneca AB Description and Major Businesses
Table 72. AstraZeneca AB Esomeprazole Production (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2015-2020)
Table 73. AstraZeneca AB Product
Table 74. AstraZeneca AB Recent Development
Table 75. Sandoz Corporation Information
Table 76. Sandoz Description and Major Businesses
Table 77. Sandoz Esomeprazole Production (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2015-2020)
Table 78. Sandoz Product
Table 79. Sandoz Recent Development
Table 80. Actavis Corporation Information
Table 81. Actavis Description and Major Businesses
Table 82. Actavis Esomeprazole Production (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2015-2020)
Table 83. Actavis Product
Table 84. Actavis Recent Development
Table 85. Teva. Corporation Information
Table 86. Teva. Description and Major Businesses
Table 87. Teva. Esomeprazole Production (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2015-2020)
Table 88. Teva. Product
Table 89. Teva. Recent Development
Table 90. Mylan Corporation Information
Table 91. Mylan Description and Major Businesses
Table 92. Mylan Esomeprazole Production (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2015-2020)
Table 93. Mylan Product
Table 94. Mylan Recent Development
Table 95. KernPharm Corporation Information
Table 96. KernPharm Description and Major Businesses
Table 97. KernPharm Esomeprazole Production (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2015-2020)
Table 98. KernPharm Product
Table 99. KernPharm Recent Development
Table 100. Garmish Pharmaceuticals Corporation Information
Table 101. Garmish Pharmaceuticals Description and Major Businesses
Table 102. Garmish Pharmaceuticals Esomeprazole Production (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2015-2020)
Table 103. Garmish Pharmaceuticals Product
Table 104. Garmish Pharmaceuticals Recent Development
Table 105. Sanofi Corporation Information
Table 106. Sanofi Description and Major Businesses
Table 107. Sanofi Esomeprazole Production (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2015-2020)
Table 108. Sanofi Product
Table 109. Sanofi Recent Development
Table 110. Mepha Corporation Information
Table 111. Mepha Description and Major Businesses
Table 112. Mepha Esomeprazole Production (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2015-2020)
Table 113. Mepha Product
Table 114. Mepha Recent Development
Table 115. Saval Pharmaceutical Corporation Information
Table 116. Saval Pharmaceutical Description and Major Businesses
Table 117. Saval Pharmaceutical Esomeprazole Production (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2015-2020)
Table 118. Saval Pharmaceutical Product
Table 119. Saval Pharmaceutical Recent Development
Table 120. Stada Corporation Information
Table 121. Stada Description and Major Businesses
Table 122. Stada Esomeprazole Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2015-2020)
Table 123. Stada Product
Table 124. Stada Recent Development
Table 125. Blaskov Corporation Information
Table 126. Blaskov Description and Major Businesses
Table 127. Blaskov Esomeprazole Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2015-2020)
Table 128. Blaskov Product
Table 129. Blaskov Recent Development
Table 130. CQ Lummy Corporation Information
Table 131. CQ Lummy Description and Major Businesses
Table 132. CQ Lummy Esomeprazole Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2015-2020)
Table 133. CQ Lummy Product
Table 134. CQ Lummy Recent Development
Table 135. Global Esomeprazole Sales Forecast by Regions (2021-2026) (K Units)
Table 136. Global Esomeprazole Sales Market Share Forecast by Regions (2021-2026)
Table 137. Global Esomeprazole Revenue Forecast by Regions (2021-2026) (US$ Million)
Table 138. Global Esomeprazole Revenue Market Share Forecast by Regions (2021-2026)
Table 139. North America: Esomeprazole Sales Forecast by Country (2021-2026) (K Units)
Table 140. North America: Esomeprazole Revenue Forecast by Country (2021-2026) (US$ Million)
Table 141. Europe: Esomeprazole Sales Forecast by Country (2021-2026) (K Units)
Table 142. Europe: Esomeprazole Revenue Forecast by Country (2021-2026) (US$ Million)
Table 143. Asia Pacific: Esomeprazole Sales Forecast by Region (2021-2026) (K Units)
Table 144. Asia Pacific: Esomeprazole Revenue Forecast by Region (2021-2026) (US$ Million)
Table 145. Latin America: Esomeprazole Sales Forecast by Country (2021-2026) (K Units)
Table 146. Latin America: Esomeprazole Revenue Forecast by Country (2021-2026) (US$ Million)
Table 147. Middle East and Africa: Esomeprazole Sales Forecast by Country (2021-2026) (K Units)
Table 148. Middle East and Africa: Esomeprazole Revenue Forecast by Country (2021-2026) (US$ Million)
Table 149. Key Opportunities and Drivers: Impact Analysis (2021-2026)
Table 150. Key Challenges
Table 151. Market Risks
Table 152. Main Points Interviewed from Key Esomeprazole Players
Table 153. Esomeprazole Customers List
Table 154. Esomeprazole Distributors List
Table 155. Research Programs/Design for This Report
Table 156. Key Data Information from Secondary Sources
Table 157. Key Data Information from Primary Sources
List of Figures
Figure 1. Esomeprazole Product Picture
Figure 2. Global Esomeprazole Sales Market Share by Type in 2020 & 2026
Figure 3. Capsule Product Picture
Figure 4. Tablet Product Picture
Figure 5. Others Product Picture
Figure 6. Global Esomeprazole Sales Market Share by Application in 2020 & 2026
Figure 7. Gastroesophageal Reflux Disease
Figure 8. Duodenal Ulcers
Figure 9. Others
Figure 10. Esomeprazole Report Years Considered
Figure 11. Global Esomeprazole Market Size 2015-2026 (US$ Million)
Figure 12. Global Esomeprazole Sales 2015-2026 (K Units)
Figure 13. Global Esomeprazole Market Size Market Share by Region: 2020 Versus 2026
Figure 14. Global Esomeprazole Sales Market Share by Region (2015-2020)
Figure 15. Global Esomeprazole Sales Market Share by Region in 2019
Figure 16. Global Esomeprazole Revenue Market Share by Region (2015-2020)
Figure 17. Global Esomeprazole Revenue Market Share by Region in 2019
Figure 18. Global Esomeprazole Sales Share by Manufacturer in 2019
Figure 19. The Top 10 and 5 Players Market Share by Esomeprazole Revenue in 2019
Figure 20. Esomeprazole Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2015 VS 2019
Figure 21. Global Esomeprazole Sales Market Share by Type (2015-2020)
Figure 22. Global Esomeprazole Sales Market Share by Type in 2019
Figure 23. Global Esomeprazole Revenue Market Share by Type (2015-2020)
Figure 24. Global Esomeprazole Revenue Market Share by Type in 2019
Figure 25. Global Esomeprazole Market Share by Price Range (2015-2020)
Figure 26. Global Esomeprazole Sales Market Share by Application (2015-2020)
Figure 27. Global Esomeprazole Sales Market Share by Application in 2019
Figure 28. Global Esomeprazole Revenue Market Share by Application (2015-2020)
Figure 29. Global Esomeprazole Revenue Market Share by Application in 2019
Figure 30. North America Esomeprazole Sales Growth Rate 2015-2020 (K Units)
Figure 31. North America Esomeprazole Revenue Growth Rate 2015-2020 (US$ Million)
Figure 32. North America Esomeprazole Sales Market Share by Country in 2019
Figure 33. North America Esomeprazole Revenue Market Share by Country in 2019
Figure 34. U.S. Esomeprazole Sales Growth Rate (2015-2020) (K Units)
Figure 35. U.S. Esomeprazole Revenue Growth Rate (2015-2020) (US$ Million)
Figure 36. Canada Esomeprazole Sales Growth Rate (2015-2020) (K Units)
Figure 37. Canada Esomeprazole Revenue Growth Rate (2015-2020) (US$ Million)
Figure 38. North America Esomeprazole Market Share by Type in 2019
Figure 39. North America Esomeprazole Market Share by Application in 2019
Figure 40. Europe Esomeprazole Sales Growth Rate 2015-2020 (K Units)
Figure 41. Europe Esomeprazole Revenue Growth Rate 2015-2020 (US$ Million)
Figure 42. Europe Esomeprazole Sales Market Share by Country in 2019
Figure 43. Europe Esomeprazole Revenue Market Share by Country in 2019
Figure 44. Germany Esomeprazole Sales Growth Rate (2015-2020) (K Units)
Figure 45. Germany Esomeprazole Revenue Growth Rate (2015-2020) (US$ Million)
Figure 46. France Esomeprazole Sales Growth Rate (2015-2020) (K Units)
Figure 47. France Esomeprazole Revenue Growth Rate (2015-2020) (US$ Million)
Figure 48. U.K. Esomeprazole Sales Growth Rate (2015-2020) (K Units)
Figure 49. U.K. Esomeprazole Revenue Growth Rate (2015-2020) (US$ Million)
Figure 50. Italy Esomeprazole Sales Growth Rate (2015-2020) (K Units)
Figure 51. Italy Esomeprazole Revenue Growth Rate (2015-2020) (US$ Million)
Figure 52. Russia Esomeprazole Sales Growth Rate (2015-2020) (K Units)
Figure 53. Russia Esomeprazole Revenue Growth Rate (2015-2020) (US$ Million)
Figure 54. Europe Esomeprazole Market Share by Type in 2019
Figure 55. Europe Esomeprazole Market Share by Application in 2019
Figure 56. Asia Pacific Esomeprazole Sales Growth Rate 2015-2020 (K Units)
Figure 57. Asia Pacific Esomeprazole Revenue Growth Rate 2015-2020 (US$ Million)
Figure 58. Asia Pacific Esomeprazole Sales Market Share by Region in 2019
Figure 59. Asia Pacific Esomeprazole Revenue Market Share by Region in 2019
Figure 60. China Esomeprazole Sales Growth Rate (2015-2020) (K Units)
Figure 61. China Esomeprazole Revenue Growth Rate (2015-2020) (US$ Million)
Figure 62. Japan Esomeprazole Sales Growth Rate (2015-2020) (K Units)
Figure 63. Japan Esomeprazole Revenue Growth Rate (2015-2020) (US$ Million)
Figure 64. South Korea Esomeprazole Sales Growth Rate (2015-2020) (K Units)
Figure 65. South Korea Esomeprazole Revenue Growth Rate (2015-2020) (US$ Million)
Figure 66. India Esomeprazole Sales Growth Rate (2015-2020) (K Units)
Figure 67. India Esomeprazole Revenue Growth Rate (2015-2020) (US$ Million)
Figure 68. Australia Esomeprazole Sales Growth Rate (2015-2020) (K Units)
Figure 69. Australia Esomeprazole Revenue Growth Rate (2015-2020) (US$ Million)
Figure 70. Taiwan Esomeprazole Sales Growth Rate (2015-2020) (K Units)
Figure 71. Taiwan Esomeprazole Revenue Growth Rate (2015-2020) (US$ Million)
Figure 72. Indonesia Esomeprazole Sales Growth Rate (2015-2020) (K Units)
Figure 73. Indonesia Esomeprazole Revenue Growth Rate (2015-2020) (US$ Million)
Figure 74. Thailand Esomeprazole Sales Growth Rate (2015-2020) (K Units)
Figure 75. Thailand Esomeprazole Revenue Growth Rate (2015-2020) (US$ Million)
Figure 76. Malaysia Esomeprazole Sales Growth Rate (2015-2020) (K Units)
Figure 77. Malaysia Esomeprazole Revenue Growth Rate (2015-2020) (US$ Million)
Figure 78. Philippines Esomeprazole Sales Growth Rate (2015-2020) (K Units)
Figure 79. Philippines Esomeprazole Revenue Growth Rate (2015-2020) (US$ Million)
Figure 80. Vietnam Esomeprazole Sales Growth Rate (2015-2020) (K Units)
Figure 81. Vietnam Esomeprazole Revenue Growth Rate (2015-2020) (US$ Million)
Figure 82. Asia Pacific Esomeprazole Market Share by Type in 2019
Figure 83. Asia Pacific Esomeprazole Market Share by Application in 2019
Figure 84. Latin America Esomeprazole Sales Growth Rate 2015-2020 (K Units)
Figure 85. Latin America Esomeprazole Revenue Growth Rate 2015-2020 (US$ Million)
Figure 86. Latin America Esomeprazole Sales Market Share by Country in 2019
Figure 87. Latin America Esomeprazole Revenue Market Share by Country in 2019
Figure 88. Mexico Esomeprazole Sales Growth Rate (2015-2020) (K Units)
Figure 89. Mexico Esomeprazole Revenue Growth Rate (2015-2020) (US$ Million)
Figure 90. Brazil Esomeprazole Sales Growth Rate (2015-2020) (K Units)
Figure 91. Brazil Esomeprazole Revenue Growth Rate (2015-2020) (US$ Million)
Figure 92. Argentina Esomeprazole Sales Growth Rate (2015-2020) (K Units)
Figure 93. Argentina Esomeprazole Revenue Growth Rate (2015-2020) (US$ Million)
Figure 94. Latin America Esomeprazole Market Share by Type in 2019
Figure 95. Latin America Esomeprazole Market Share by Application in 2019
Figure 96. Middle East and Africa Esomeprazole Sales Growth Rate 2015-2020 (K Units)
Figure 97. Middle East and Africa Esomeprazole Revenue Growth Rate 2015-2020 (US$ Million)
Figure 98. Middle East and Africa Esomeprazole Sales Market Share by Country in 2019
Figure 99. Middle East and Africa Esomeprazole Revenue Market Share by Country in 2019
Figure 100. Turkey Esomeprazole Sales Growth Rate (2015-2020) (K Units)
Figure 101. Turkey Esomeprazole Revenue Growth Rate (2015-2020) (US$ Million)
Figure 102. Saudi Arabia Esomeprazole Sales Growth Rate (2015-2020) (K Units)
Figure 103. Saudi Arabia Esomeprazole Revenue Growth Rate (2015-2020) (US$ Million)
Figure 104. U.A.E Esomeprazole Sales Growth Rate (2015-2020) (K Units)
Figure 105. U.A.E Esomeprazole Revenue Growth Rate (2015-2020) (US$ Million)
Figure 106. Middle East and Africa Esomeprazole Market Share by Type in 2019
Figure 107. Middle East and Africa Esomeprazole Market Share by Application in 2019
Figure 108. North America Esomeprazole Sales Growth Rate Forecast (2021-2026) (K Units)
Figure 109. North America Esomeprazole Revenue Growth Rate Forecast (2021-2026) (US$ Million)
Figure 110. Europe Esomeprazole Sales Growth Rate Forecast (2021-2026) (K Units)
Figure 111. Europe Esomeprazole Revenue Growth Rate Forecast (2021-2026) (US$ Million)
Figure 112. Asia Pacific Esomeprazole Sales Growth Rate Forecast (2021-2026) (K Units)
Figure 113. Asia Pacific Esomeprazole Revenue Growth Rate Forecast (2021-2026) (US$ Million)
Figure 114. Latin America Esomeprazole Sales Growth Rate Forecast (2021-2026) (K Units)
Figure 115. Latin America Esomeprazole Revenue Growth Rate Forecast (2021-2026) (US$ Million)
Figure 116. Middle East and Africa Esomeprazole Sales Growth Rate Forecast (2021-2026) (K Units)
Figure 117. Middle East and Africa Esomeprazole Revenue Growth Rate Forecast (2021-2026) (US$ Million)
Figure 118. Porter's Five Forces Analysis
Figure 119. Channels of Distribution
Figure 120. Distributors Profiles
Figure 121. Bottom-up and Top-down Approaches for This Report
Figure 122. Data Triangulation
Figure 123. Key Executives Interviewed
胃食道逆流症（GERD）治療薬の世界市場（～2026年） Gastroesophageal reflux disease (GERD), also known as acid reflux, is a long-term condition where stomach contents come back up into the esophagus resulting in either symptoms or complications. Patent expiry of blockbuster drugs prescribed for the treatment of acid reflux disorders is majorly attrib…- 十二指腸潰瘍治療の世界市場（～2026年） Duodenal ulcer is a sore occurring in the upper area of the small intestine, the duodenum. Globally demand for duodenal ulcer treatment is expected to witness growth due to increasing prevalence of the disease. Market Analysis and Insights: Global Duodenal Ulcer Treatment Market The global Duodenal …
- 逆流性腎症治療の世界市場（～2026年） Reflux nephropathy is kidney damage (nephropathy) due to urine flowing backward (reflux) from the bladder toward the kidneys. The symptoms of reflux nephropathy are comparable to nephrotic syndrome and infection of the urinary tract, though some individuals may not exhibit any evidence (symptom) of …
- 糖尿病性足潰瘍・褥瘡の世界市場（～2026年） Diabetic foot ulcers, are most common chronic wounds in patients suffering from diabetes, and lack of proper treatment of the foot ulcers often lead to progression of the wound resulting in lower extremity / foot amputation. Pressure ulcers are often a cause of lack of movement of the patients, long…
- 褥瘡治療の世界市場（～2026年） Pressure ulcers are injuries caused to skin and tissue due to prolonged pressure on skin. Pressure ulcer is not lethal; however, extreme stages of pressure ulcer can cause infection. The home health care segment held the smallest market share in 2017. However, the segment is anticipated to expand at…